Study number 779857
Dates
May 05 2026-Jul 15 2026
Group
C7
Location
Madison, Wisconsin
Age
18-65
Gender
Male and Female
Smokers Allowed
Yes
Compensation
$12,049
Referral
$350
This is a research study for a drug approved by the U.S Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. This study drug is also being developed for the potential treatment of autoimmune diseases, conditions in which the immune system mistakenly attacks the body.
Madison, WI is currently recruiting Healthy Adults, ages 18-65.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
Smoking Criteria
Body Mass Index
Screening procedures
C7
Check-in: May 5
Check-out: May 6
Follow-up visits:
Phone calls: